Literature DB >> 31399847

Extensor/flexor ratio of neck muscle strength and electromyographic activity of individuals with migraine: a cross-sectional study.

Mariana Tedeschi Benatto1, Lidiane Lima Florencio2, Marcela Mendes Bragatto3, Samuel Straceri Lodovichi3, Fabíola Dach4, Débora Bevilaqua-Grossi3.   

Abstract

PURPOSE: Neck pain is considered a common characteristic of migraine attacks. The relationship between neck pain and migraine can be explained by central sensitization of the trigeminocervical complex, where superior cervical afferents and the trigeminal nerve converge. However, few studies have evaluated motor control of cervical muscles in individuals with migraine. Thus, the purpose of the present study was to determine the extensor/flexor ratio of neck muscle strength and electromyographic activity during a test of maximal voluntary isometric contraction and craniocervical flexion in individuals with migraine and individuals without history of migraine or other headaches.
METHODS: Fifty-two women with the disease and 52 women with neither a history of migraine nor neck pain, between 18 and 55 years old, were included in the study. The electromyographic activities of the sternocleidomastoid, anterior scalene, splenius capitis, and upper trapezius muscles were evaluated during a test of maximal voluntary isometric contraction and craniocervical flexion.
RESULTS: The migraine group presented lower flexor muscle strength and a higher extensor/flexor muscle strength ratio than the control group. In addition, the migraine group showed a reduced electromyographic extensor/flexor muscle ratio during maximal voluntary isometric contraction in flexion. The results demonstrated worse performance in the craniocervical flexion test of the migraine group and a lower electromyographic ratio of extensor/flexor neck muscles in the last stage of the test.
CONCLUSION: Altogether, the migraine group presented an imbalance in cervical muscles verified not only during force production, but also during muscle activity. These slides can be retrieved under Electronic Supplementary Material.

Entities:  

Keywords:  Electromyographic; Extension/flexion ratio; Migraine disorders; Neck pain

Mesh:

Year:  2019        PMID: 31399847     DOI: 10.1007/s00586-019-06097-9

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  5 in total

1.  Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache - a protocol of a pragmatic randomized controlled trial.

Authors:  Kiran Satpute; Nilima Bedekar; Toby Hall
Journal:  BMC Musculoskelet Disord       Date:  2021-03-03       Impact factor: 2.362

2.  Neck-specific strengthening exercise compared with placebo sham ultrasound in patients with migraine: a randomized controlled trial.

Authors:  Mariana Tedeschi Benatto; Lidiane Lima Florencio; Marcela Mendes Bragatto; Fabíola Dach; César Fernández-de-Las-Peñas; Débora Bevilaqua-Grossi
Journal:  BMC Neurol       Date:  2022-04-02       Impact factor: 2.474

Review 3.  The mouth-opening muscular performance in adults with and without temporomandibular disorders: A systematic review.

Authors:  Tzvika Greenbaum; Laurent Pitance; Ron Kedem; Alona Emodi-Perlman
Journal:  J Oral Rehabil       Date:  2022-01-31       Impact factor: 3.558

4.  The Mode of Activity of Cervical Extensors and Flexors in Healthy Adults: A Cross-Sectional Study.

Authors:  Hiroyoshi Yajima; Ruka Nobe; Miho Takayama; Nobuari Takakura
Journal:  Medicina (Kaunas)       Date:  2022-05-28       Impact factor: 2.948

5.  Comparison of cervical muscle isometric force between migraine subgroups or migraine-associated neck pain: a controlled study.

Authors:  Lidiane Lima Florencio; Anamaria Siriani de Oliveira; Carina Ferreira Pinheiro; Tenysson Will-Lemos; Fabíola Dach; César Fernández-de-Las-Peñas; Débora Bevilaqua-Grossi
Journal:  Sci Rep       Date:  2021-07-29       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.